Fabian Kausche

Dr. Kausche was appointed Chairman of the Board of PetMedix in March 2019. He has several decades of senior executive experience in the animal and human health industries in both biological and pharmaceutical research and development.

Dr. Kausche held subsequent positions as Global Head of Research & Development for three of the top eight global Animal Health companies: Novartis Animal Health, Merial, and Boehringer Ingelheim Animal Health. In addition to his extensive Animal Health R&D experience, he gained expertise in the human health space as head of R&D for Novartis Consumer Health. Prior to that, he also successfully led a companion animal sales force for Novartis Animal Health.

A native of Germany, Dr. Kausche received a veterinary degree from the Hannover Veterinary School. He subsequently completed a Master’s of Science degree at Iowa State University. Following the completion of the M.S. degree, Dr. Kausche returned to Europe and obtained the German PhD (Dr.med.vet.) in a combination program between the Hannover Medical and Veterinary Schools. Having completed the Advanced Management Program in 2005, he is also an alumnus of Harvard Business School.